Mesa LaboratoriesMLAB +4.32%77 PS Ratio is 2.29 as of Jun. 27, 2026, which is 58% below its 10-year median of 5.49. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.05 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 2,467 Hardware companies, Mesa Laboratories ranks worse than 52.82% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Mesa Laboratories's share price is $102.42.
Mesa Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $44.77. Hence, Mesa Laboratories's PS Ratio for today is 2.29.
Warning Sign:
Mesa Laboratories Inc stock PS Ratio (=2.29) is close to 1-year high of 2.43.
The historical rank and industry rank for Mesa Laboratories's PS Ratio or its related term are showing as below:
MLAB'
s PS Ratio Range Over the Past 10 Years
Min: 1.39 Med: 5.49 Max: 12.37
Current: 2.29
During the past 13 years, Mesa Laboratories's highest PS Ratio was 12.37. The lowest was 1.39. And the median was 5.49.
MLAB's PS Ratio is ranked worse than 52.82% of 2467
companies
in the Hardware industry
Industry Median: 1.96
vs MLAB: 2.29
Mesa Laboratories Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Mesa Laboratories was 0.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year.
During the past 13 years, Mesa Laboratories's highest 3-Year average Revenue per Share Growth Rate was 26.30% per year. The lowest was 0.80% per year. And the median was 11.30% per year.
Back to Basics: PS Ratio
Mesa Laboratories (NAS:MLAB) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Mesa Laboratories PS Ratio Related Terms
Mesa Laboratories PS Ratio Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories PS Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's PS Ratio distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Mesa Laboratories's Share Price of today is $102.42. Mesa Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Mesa Laboratories (MLAB) has a PS Ratio of 2.29 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Mesa Laboratories and its competitors. This is 58% below median its historical median of 5.49. Over the past decade, Mesa Laboratories' PS Ratio has ranged from 1.39 to 12.37. According to the industry distribution chart, Mesa Laboratories ranks #1303 out of 2467 companies in the Hardware industry, placing it in the top 52.8%.
Is Mesa Laboratories' PS Ratio too high?
Mesa Laboratories' current PS Ratio of 2.29 is 58% below median its 10-year median of 5.49. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 12.37. The Hardware industry median PS Ratio is 1.96. Mesa Laboratories' value of 2.29 is 16.8% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #1303 out of 2467 companies in the Hardware industry, which is below the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' PS Ratio compare to AERG and MVIS?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #1303 out of 2467 companies for PS Ratio. This places Mesa Laboratories in the lower half of its industry. The industry median PS Ratio is 1.96. Mesa Laboratories' value of 2.29 is 16.8% above this benchmark. Historically, Mesa Laboratories' own PS Ratio has ranged from 1.39 to 12.37 over the past decade. While the company's 10-year median is 5.49 vs. the industry median of 1.96, Mesa Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Hardware company?
The median PS Ratio among Hardware companies is 1.96, based on 2,467 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current PS Ratio of 2.29 is 16.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median PS Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current PS Ratio is 2.29, which is 58% below median its own 10-year median of 5.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $102.42 — trading 11.7% below its estimated fair value. The current PS Ratio is 2.29, which is 58% below median its 10-year median of 5.49 and 16.8% above the Hardware industry median of 1.96. Mesa Laboratories' overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current PS Ratio is 2.29 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $102.42 is trading 11.7% below its estimated GF Value™ of $116.05.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
PS Ratio: 2.29 (58% below median its 10-year median of 5.49)
GF Value™: $116.05 vs. price of $102.42 (11.7% below fair value)
Industry Position: 16.8% above the Hardware median (#1303 of 2467)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score
Get the complete analysis for MLAB
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
